Symposium 11- Precision Dosing Reimagined: TDM of New Biological Modalities in Oncology

08:30 • IS11-01 • Innovations in TDM for Bispecifics and ADCs: Addressing challenges in exposure-response relationships, immunogenicity, and interpatient variability > N. Nikki KERSSEMAKERS 09:00 • IS11-02 • Cellular Therapies and TDM: Monitoring CAR-T therapies – Pharmacokinetics, expansion kinetics, and cytokine profiles > D. David TERNANT 09:30 • IS11-03 • Biomarker-Guided Dosing in Oncology: Leveraging soluble targets, cytokines, and tumor burden to inform individualized dosing > V. Vikram GOTA